Last reviewed · How we verify

NCT04181125

"Evaluation of Postural Control in Children With Increased Femoral Anteversion"

Completed Last updated 24 November 2020
What this trial tests

trial testing Biodex Balance System in Femoral Anteversion in 32 participants. Completed in 1 November 2020.

Timeline
1 April 2019
Primary endpoint
1 September 2020
1 November 2020

Quick facts

Lead sponsorBezmialem Vakif University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment32
Start date1 April 2019
Primary completion1 September 2020
Estimated completion1 November 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bezmialem Vakif University

Who can join

Adults 7 to 15, any sex, with Femoral Anteversion or Gait Disorders in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The relationship between increased femoral anteversion and postural control in healthy children has not been studied in the current literature. To our knowledge there is no study to evaluate postural control in children with increased femoral anteversion by computerized posturography. We aimed to evaluate postural control in children with increased femoral anteversion using computerized dynamic posturography (Biodex Balance System).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Biodex Balance System

Trials testing the same drug.

Other Bezmialem Vakif University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04181125.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing